Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments

This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Environmental science and pollution research international 2016-06, Vol.23 (11), p.11209-11223
Hauptverfasser: Česen, Marjeta, Kosjek, Tina, Busetti, Francesco, Kompare, Boris, Heath, Ester
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11223
container_issue 11
container_start_page 11209
container_title Environmental science and pollution research international
container_volume 23
creator Česen, Marjeta
Kosjek, Tina
Busetti, Francesco
Kompare, Boris
Heath, Ester
description This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl-ifosfamide/ N -dechloroethyl-cyclophosphamide ( N -decl-CP) in wastewater (WW). Keto-cyclophosphamide, CP and IF were extracted with Oasis HLB and N -decl-CP and carboxy-CP with Isolute ENV+ cartridges. Analyte derivatization was performed by silylation (metabolites/TPs) and acetylation (CP and IF). The recoveries and LOQs of the developed method were 58, 87 and 103 % and 77.7, 43.7 and 6.7 ng L −1 for carboxy-CP, keto-CP and N -decl-CP, respectively. After validation, the analytical method was applied to hospital WW and influent and effluent samples of a receiving WW treatment plant. In hospital WW, levels up to 2690, 47.0, 13,200, 2100 and 178 ng L −1 were detected for CP, IF, carboxy-CP, N -decl-CP and keto-CP, respectively, while in influent and effluent samples concentrations were below LOQs. The formation of TPs during abiotic treatments was also studied. Liquid chromatography-high-resolution mass spectrometry was used to identify CP and IF TPs in ultrapure water, treated with UV and UV/H 2 O 2 . UV treatment produced four CP TPs and four IF TPs, while UV/H 2 O 2 resulted in five CPs and four IF TPs. Besides already known TPs, three novel TPs (CP-TP138a, imino-ifosfamide and IF-TP138) have been tentatively identified. In hospital WW treated by UV/O 3 /H 2 O 2 , none of the target metabolites/TPs resulted above LOQs.
doi_str_mv 10.1007/s11356-016-6321-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808732719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4071178281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-7a4383962b8bd999e9f9551bdd88850704ea7ef9ffdcdbf94654999103b821273</originalsourceid><addsrcrecordid>eNqFkcuKFTEURYMo9rX1A5xIgRMHluYkqTycSaO20OBExyGVh52mqlImqcH9Cb_Z3K72gSCOwoF19iF7IfQU8CvAWLwuAHTgPQbec0qgh3voABxYL5hS99EBK8Z6oIydoUel3GBMsCLiITojXBE8UHZA3y-32Szd7KsZ0xSrL51ZXFezWUpIeTY1pqVbc3KbraVLobNHO6X1OpX12szR-Vs-hlTC7fimzWY6llhedsnaLWe_2B36nee2HJevnRljqtG2a97U2S-1PEYPgpmKf3L3nqMv7999vrjsrz59-Hjx9qq3jJHaC8OopIqTUY5OKeVVUMMAo3NSygELzLwRPqgQnHVjUIwPrREFmI6SABH0HL3Yc9vPvm2-VD3HYv00mcWnrWiQWApKBKj_o6J1KoggvKHP_0Jv0pZbHTtFOMESNwp2yuZUSvZBrznOJh81YH3yqnevunnVJ68a2s6zu-RtnL37tfFTZAPIDpT1VK3Pf5z-Z-oPdxGvqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792262080</pqid></control><display><type>article</type><title>Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Česen, Marjeta ; Kosjek, Tina ; Busetti, Francesco ; Kompare, Boris ; Heath, Ester</creator><creatorcontrib>Česen, Marjeta ; Kosjek, Tina ; Busetti, Francesco ; Kompare, Boris ; Heath, Ester</creatorcontrib><description>This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl-ifosfamide/ N -dechloroethyl-cyclophosphamide ( N -decl-CP) in wastewater (WW). Keto-cyclophosphamide, CP and IF were extracted with Oasis HLB and N -decl-CP and carboxy-CP with Isolute ENV+ cartridges. Analyte derivatization was performed by silylation (metabolites/TPs) and acetylation (CP and IF). The recoveries and LOQs of the developed method were 58, 87 and 103 % and 77.7, 43.7 and 6.7 ng L −1 for carboxy-CP, keto-CP and N -decl-CP, respectively. After validation, the analytical method was applied to hospital WW and influent and effluent samples of a receiving WW treatment plant. In hospital WW, levels up to 2690, 47.0, 13,200, 2100 and 178 ng L −1 were detected for CP, IF, carboxy-CP, N -decl-CP and keto-CP, respectively, while in influent and effluent samples concentrations were below LOQs. The formation of TPs during abiotic treatments was also studied. Liquid chromatography-high-resolution mass spectrometry was used to identify CP and IF TPs in ultrapure water, treated with UV and UV/H 2 O 2 . UV treatment produced four CP TPs and four IF TPs, while UV/H 2 O 2 resulted in five CPs and four IF TPs. Besides already known TPs, three novel TPs (CP-TP138a, imino-ifosfamide and IF-TP138) have been tentatively identified. In hospital WW treated by UV/O 3 /H 2 O 2 , none of the target metabolites/TPs resulted above LOQs.</description><identifier>ISSN: 0944-1344</identifier><identifier>EISSN: 1614-7499</identifier><identifier>DOI: 10.1007/s11356-016-6321-1</identifier><identifier>PMID: 26920534</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Analytical methods ; Antineoplastic Agents, Alkylating - analysis ; Antineoplastic Agents, Alkylating - metabolism ; Aquatic Pollution ; Atmospheric Protection/Air Quality Control/Air Pollution ; Cell division ; Chemotherapy ; Chromatography ; Cyclophosphamide - analysis ; Cyclophosphamide - metabolism ; Cytotoxicity ; Earth and Environmental Science ; Ecotoxicology ; Effluents ; Environment ; Environmental Chemistry ; Environmental Health ; Environmental Monitoring - methods ; Environmental science ; Gas chromatography ; Gas Chromatography-Mass Spectrometry - methods ; Hospitals ; Humans ; Hydrogen peroxide ; Ifosfamide - analysis ; Ifosfamide - metabolism ; Liquid chromatography ; Mass spectrometry ; Metabolites ; Research Article ; Scientific imaging ; Studies ; Waste Water - analysis ; Waste Water Technology ; Water Management ; Water Pollutants, Chemical - analysis ; Water Pollutants, Chemical - metabolism ; Water Pollution Control ; Water treatment</subject><ispartof>Environmental science and pollution research international, 2016-06, Vol.23 (11), p.11209-11223</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-7a4383962b8bd999e9f9551bdd88850704ea7ef9ffdcdbf94654999103b821273</citedby><cites>FETCH-LOGICAL-c442t-7a4383962b8bd999e9f9551bdd88850704ea7ef9ffdcdbf94654999103b821273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11356-016-6321-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11356-016-6321-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26920534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Česen, Marjeta</creatorcontrib><creatorcontrib>Kosjek, Tina</creatorcontrib><creatorcontrib>Busetti, Francesco</creatorcontrib><creatorcontrib>Kompare, Boris</creatorcontrib><creatorcontrib>Heath, Ester</creatorcontrib><title>Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments</title><title>Environmental science and pollution research international</title><addtitle>Environ Sci Pollut Res</addtitle><addtitle>Environ Sci Pollut Res Int</addtitle><description>This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl-ifosfamide/ N -dechloroethyl-cyclophosphamide ( N -decl-CP) in wastewater (WW). Keto-cyclophosphamide, CP and IF were extracted with Oasis HLB and N -decl-CP and carboxy-CP with Isolute ENV+ cartridges. Analyte derivatization was performed by silylation (metabolites/TPs) and acetylation (CP and IF). The recoveries and LOQs of the developed method were 58, 87 and 103 % and 77.7, 43.7 and 6.7 ng L −1 for carboxy-CP, keto-CP and N -decl-CP, respectively. After validation, the analytical method was applied to hospital WW and influent and effluent samples of a receiving WW treatment plant. In hospital WW, levels up to 2690, 47.0, 13,200, 2100 and 178 ng L −1 were detected for CP, IF, carboxy-CP, N -decl-CP and keto-CP, respectively, while in influent and effluent samples concentrations were below LOQs. The formation of TPs during abiotic treatments was also studied. Liquid chromatography-high-resolution mass spectrometry was used to identify CP and IF TPs in ultrapure water, treated with UV and UV/H 2 O 2 . UV treatment produced four CP TPs and four IF TPs, while UV/H 2 O 2 resulted in five CPs and four IF TPs. Besides already known TPs, three novel TPs (CP-TP138a, imino-ifosfamide and IF-TP138) have been tentatively identified. In hospital WW treated by UV/O 3 /H 2 O 2 , none of the target metabolites/TPs resulted above LOQs.</description><subject>Analytical methods</subject><subject>Antineoplastic Agents, Alkylating - analysis</subject><subject>Antineoplastic Agents, Alkylating - metabolism</subject><subject>Aquatic Pollution</subject><subject>Atmospheric Protection/Air Quality Control/Air Pollution</subject><subject>Cell division</subject><subject>Chemotherapy</subject><subject>Chromatography</subject><subject>Cyclophosphamide - analysis</subject><subject>Cyclophosphamide - metabolism</subject><subject>Cytotoxicity</subject><subject>Earth and Environmental Science</subject><subject>Ecotoxicology</subject><subject>Effluents</subject><subject>Environment</subject><subject>Environmental Chemistry</subject><subject>Environmental Health</subject><subject>Environmental Monitoring - methods</subject><subject>Environmental science</subject><subject>Gas chromatography</subject><subject>Gas Chromatography-Mass Spectrometry - methods</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hydrogen peroxide</subject><subject>Ifosfamide - analysis</subject><subject>Ifosfamide - metabolism</subject><subject>Liquid chromatography</subject><subject>Mass spectrometry</subject><subject>Metabolites</subject><subject>Research Article</subject><subject>Scientific imaging</subject><subject>Studies</subject><subject>Waste Water - analysis</subject><subject>Waste Water Technology</subject><subject>Water Management</subject><subject>Water Pollutants, Chemical - analysis</subject><subject>Water Pollutants, Chemical - metabolism</subject><subject>Water Pollution Control</subject><subject>Water treatment</subject><issn>0944-1344</issn><issn>1614-7499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkcuKFTEURYMo9rX1A5xIgRMHluYkqTycSaO20OBExyGVh52mqlImqcH9Cb_Z3K72gSCOwoF19iF7IfQU8CvAWLwuAHTgPQbec0qgh3voABxYL5hS99EBK8Z6oIydoUel3GBMsCLiITojXBE8UHZA3y-32Szd7KsZ0xSrL51ZXFezWUpIeTY1pqVbc3KbraVLobNHO6X1OpX12szR-Vs-hlTC7fimzWY6llhedsnaLWe_2B36nee2HJevnRljqtG2a97U2S-1PEYPgpmKf3L3nqMv7999vrjsrz59-Hjx9qq3jJHaC8OopIqTUY5OKeVVUMMAo3NSygELzLwRPqgQnHVjUIwPrREFmI6SABH0HL3Yc9vPvm2-VD3HYv00mcWnrWiQWApKBKj_o6J1KoggvKHP_0Jv0pZbHTtFOMESNwp2yuZUSvZBrznOJh81YH3yqnevunnVJ68a2s6zu-RtnL37tfFTZAPIDpT1VK3Pf5z-Z-oPdxGvqQ</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Česen, Marjeta</creator><creator>Kosjek, Tina</creator><creator>Busetti, Francesco</creator><creator>Kompare, Boris</creator><creator>Heath, Ester</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7SN</scope><scope>7T7</scope><scope>7TV</scope><scope>7U7</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>P64</scope><scope>PATMY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>7X8</scope><scope>7ST</scope><scope>SOI</scope></search><sort><creationdate>20160601</creationdate><title>Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments</title><author>Česen, Marjeta ; Kosjek, Tina ; Busetti, Francesco ; Kompare, Boris ; Heath, Ester</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-7a4383962b8bd999e9f9551bdd88850704ea7ef9ffdcdbf94654999103b821273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analytical methods</topic><topic>Antineoplastic Agents, Alkylating - analysis</topic><topic>Antineoplastic Agents, Alkylating - metabolism</topic><topic>Aquatic Pollution</topic><topic>Atmospheric Protection/Air Quality Control/Air Pollution</topic><topic>Cell division</topic><topic>Chemotherapy</topic><topic>Chromatography</topic><topic>Cyclophosphamide - analysis</topic><topic>Cyclophosphamide - metabolism</topic><topic>Cytotoxicity</topic><topic>Earth and Environmental Science</topic><topic>Ecotoxicology</topic><topic>Effluents</topic><topic>Environment</topic><topic>Environmental Chemistry</topic><topic>Environmental Health</topic><topic>Environmental Monitoring - methods</topic><topic>Environmental science</topic><topic>Gas chromatography</topic><topic>Gas Chromatography-Mass Spectrometry - methods</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hydrogen peroxide</topic><topic>Ifosfamide - analysis</topic><topic>Ifosfamide - metabolism</topic><topic>Liquid chromatography</topic><topic>Mass spectrometry</topic><topic>Metabolites</topic><topic>Research Article</topic><topic>Scientific imaging</topic><topic>Studies</topic><topic>Waste Water - analysis</topic><topic>Waste Water Technology</topic><topic>Water Management</topic><topic>Water Pollutants, Chemical - analysis</topic><topic>Water Pollutants, Chemical - metabolism</topic><topic>Water Pollution Control</topic><topic>Water treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Česen, Marjeta</creatorcontrib><creatorcontrib>Kosjek, Tina</creatorcontrib><creatorcontrib>Busetti, Francesco</creatorcontrib><creatorcontrib>Kompare, Boris</creatorcontrib><creatorcontrib>Heath, Ester</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Ecology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Pollution Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Environment Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Environmental science and pollution research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Česen, Marjeta</au><au>Kosjek, Tina</au><au>Busetti, Francesco</au><au>Kompare, Boris</au><au>Heath, Ester</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments</atitle><jtitle>Environmental science and pollution research international</jtitle><stitle>Environ Sci Pollut Res</stitle><addtitle>Environ Sci Pollut Res Int</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>23</volume><issue>11</issue><spage>11209</spage><epage>11223</epage><pages>11209-11223</pages><issn>0944-1344</issn><eissn>1614-7499</eissn><abstract>This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl-ifosfamide/ N -dechloroethyl-cyclophosphamide ( N -decl-CP) in wastewater (WW). Keto-cyclophosphamide, CP and IF were extracted with Oasis HLB and N -decl-CP and carboxy-CP with Isolute ENV+ cartridges. Analyte derivatization was performed by silylation (metabolites/TPs) and acetylation (CP and IF). The recoveries and LOQs of the developed method were 58, 87 and 103 % and 77.7, 43.7 and 6.7 ng L −1 for carboxy-CP, keto-CP and N -decl-CP, respectively. After validation, the analytical method was applied to hospital WW and influent and effluent samples of a receiving WW treatment plant. In hospital WW, levels up to 2690, 47.0, 13,200, 2100 and 178 ng L −1 were detected for CP, IF, carboxy-CP, N -decl-CP and keto-CP, respectively, while in influent and effluent samples concentrations were below LOQs. The formation of TPs during abiotic treatments was also studied. Liquid chromatography-high-resolution mass spectrometry was used to identify CP and IF TPs in ultrapure water, treated with UV and UV/H 2 O 2 . UV treatment produced four CP TPs and four IF TPs, while UV/H 2 O 2 resulted in five CPs and four IF TPs. Besides already known TPs, three novel TPs (CP-TP138a, imino-ifosfamide and IF-TP138) have been tentatively identified. In hospital WW treated by UV/O 3 /H 2 O 2 , none of the target metabolites/TPs resulted above LOQs.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26920534</pmid><doi>10.1007/s11356-016-6321-1</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-1344
ispartof Environmental science and pollution research international, 2016-06, Vol.23 (11), p.11209-11223
issn 0944-1344
1614-7499
language eng
recordid cdi_proquest_miscellaneous_1808732719
source MEDLINE; SpringerNature Journals
subjects Analytical methods
Antineoplastic Agents, Alkylating - analysis
Antineoplastic Agents, Alkylating - metabolism
Aquatic Pollution
Atmospheric Protection/Air Quality Control/Air Pollution
Cell division
Chemotherapy
Chromatography
Cyclophosphamide - analysis
Cyclophosphamide - metabolism
Cytotoxicity
Earth and Environmental Science
Ecotoxicology
Effluents
Environment
Environmental Chemistry
Environmental Health
Environmental Monitoring - methods
Environmental science
Gas chromatography
Gas Chromatography-Mass Spectrometry - methods
Hospitals
Humans
Hydrogen peroxide
Ifosfamide - analysis
Ifosfamide - metabolism
Liquid chromatography
Mass spectrometry
Metabolites
Research Article
Scientific imaging
Studies
Waste Water - analysis
Waste Water Technology
Water Management
Water Pollutants, Chemical - analysis
Water Pollutants, Chemical - metabolism
Water Pollution Control
Water treatment
title Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A00%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20metabolites%20and%20transformation%20products%20of%20cyclophosphamide%20and%20ifosfamide:%20analysis,%20occurrence%20and%20formation%20during%20abiotic%20treatments&rft.jtitle=Environmental%20science%20and%20pollution%20research%20international&rft.au=%C4%8Cesen,%20Marjeta&rft.date=2016-06-01&rft.volume=23&rft.issue=11&rft.spage=11209&rft.epage=11223&rft.pages=11209-11223&rft.issn=0944-1344&rft.eissn=1614-7499&rft_id=info:doi/10.1007/s11356-016-6321-1&rft_dat=%3Cproquest_cross%3E4071178281%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1792262080&rft_id=info:pmid/26920534&rfr_iscdi=true